ConductScience.org, home

Paper · 42724844

Microplastics and nanoplastics-related genes signature predicts prognosis in pancreatic ductal adenocarcinoma and functional validation of interleukin 1 alpha.

Wang G and 4 others. Transl Cancer Res, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Microplastics and nanoplastics-related genes signature predicts prognosis in pancreatic ductal adenocarcinoma and functional validation of interleukin 1 alpha. Papers, record 42724844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42724844

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Microplastics and nanoplastics-related genes signature predicts prognosis in pancreatic ductal adenocarcinoma and functional validation of interleukin 1 alpha.
PubMed
Journal
Transl Cancer Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang GGennianhttps://orcid.org/0009-0005-8860-6641
2Cheng HHua
3Zhang YYaping
4Guo XXiaohu
5Li YYumin

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137,059,070Pancreatic cancer: Advances and challenges.Cell2023https://conductscience.org/library/papers/37059070PubMed
225,516,281Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.Genome Biol2014https://conductscience.org/library/papers/25516281PubMed
340,213,562Comprehensive pan-cancer analysis indicates key gene of p53-independent apoptosis is a novel biomarker for clinical application and chemotherapy in colorectal cancer.Front Immunol2025https://conductscience.org/library/papers/40213562PubMed
420,585,380Software survey: VOSviewer, a computer program for bibliometric mapping.Scientometrics2010https://conductscience.org/library/papers/20585380PubMed
537,798,442Therapeutic developments in pancreatic cancer.Nat Rev Gastroenterol Hepatol2024https://conductscience.org/library/papers/37798442PubMed
640,329,051Improving outcomes of patients with pancreatic cancer.Nat Rev Clin Oncol2025https://conductscience.org/library/papers/40329051PubMed
740,208,185Comprehensive Analysis of GPSM2: From Pan-Cancer Analysis to Experimental Validation.J Cell Mol Med2025https://conductscience.org/library/papers/40208185PubMed
820,805,420Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.J Immunol2010https://conductscience.org/library/papers/20805420PubMed
938,657,602IGSF8 is an innate immune checkpoint and cancer immunotherapy target.Cell2024https://conductscience.org/library/papers/38657602PubMed
1041,309,521Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF-κB and TGF-β Signaling Pathways.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41309521PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ASPM259,266PubTator's text mininghttps://conductscience.org/library/genes/259266NCBI Gene
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
IGSF893,185PubTator's text mininghttps://conductscience.org/library/genes/93185NCBI Gene
IL1A3,552PubTator's text mininghttps://conductscience.org/library/genes/3552NCBI Gene
KIF20A10,112PubTator's text mininghttps://conductscience.org/library/genes/10112NCBI Gene
SIGLEC15284,266PubTator's text mininghttps://conductscience.org/library/genes/284266NCBI Gene
XDH7,498PubTator's text mininghttps://conductscience.org/library/genes/7498NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42724844

GET https://conductscience.org/api/papers/v1/42724844/references?page=2